Intravenous recombinant human prourokinase for acute ischemic stroke: a network meta-analysis
Both 35 mg and 50 mg rhPro-UK improve early neurological outcomes. However, 40 mg rhPro-UK + ALT may offer the most favorable efficacy-safety profile. Further trials are warranted to optimize dosing strategies.
Authors
- Maurus Marques de Almeida Holanda (ORCID: https://orcid.org/0000-0003-2217-4434)
- J. Mancha Ramos (ORCID: https://orcid.org/0009-0004-5918-3873)
- João V Fernandes
Institutions
- Universidade Federal da Paraíba (BR)
Publication Details
- Journal
- Minerva Medica
- Published
- 2025-09-26
- DOI
- https://doi.org/10.23736/s0026-4806.25.09737-x
- Primary Topic
- Bee Products Chemical Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00